OUTREACH, RECRUITMENT AND EDUCATION CORE Alzheimer s disease (AD) affects 5.6 million Americans regardless of race or ethnicity. Today, more than 38 million Americans are age 65 or older; this number is expected to double in the next 25 years. The oldest old people age 85+ constitute the fastest growing segment of the U.S. population. Currently about four million people, this population could top 19 million by 2050. The racial and ethnic makeup of the older population is also expected to become significantly more diverse. In 2006, 81% of adults age 65+ were Caucasian; by 2050 this is estimated to decrease to 61%40 with approximately 14 million Hispanics, 8.6 million African Americans, and 5.8 million older adults from other racial and ethnic groups. Inequities in income, education, health services availability, and a lack of understanding of specific cultural differences in knowledge, beliefs, and attitudes may contribute to significant disparities in health outcomes and quality of life. This includes not only differences in symptom presentation, but perceptions of disease and care. If we are to truly understand preclinical AD and its myriad to presentations, risk factors, and potential treatment options, then our cohorts that participate in observational studies, clinical trials, biomarker studies, and psychosocial research has to reflect the growing changes in the US population. The overall goal of Outreach, Recruitment, and Education Core (OREC) of the NYU ADC is to provide conduits through community engagement; collaborative efforts with other NYU Centers, ADCs, and the scientific community; and novel approaches to increase the recruitment and retention of culturally diverse research population engaged in annual longitudinal assessments, biomarker research, and autopsy studies. We propose 4 Specific Aims: (1) Facilitate recruitment and retention of participants in ADC longitudinal studies and clinical trials with special emphasis on underrepresented minority groups (URG); (2) Perform outreach activities to inform and raise awareness of lay individuals, with an emphasis on URG concerning brain aging; memory loss; early detection; biomarkers; diagnostic, treatment and care options; and promote favorable attitudes towards research participation; (3) Maintain and grow educational initiatives and training opportunities; (4) Evaluate the effectiveness of our recruitment, outreach, training and educational activities. The Core coordinates educational offerings for all ADC stakeholders, from our research participants and their family members, to medical students, residents and fellows rotating through the ADC, to faculty and staff of the University, to the general public and healthcare professionals in our community and beyond, as well as an increasing number of visiting foreign scholars.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG008051-27
Application #
9088207
Study Section
Special Emphasis Panel (ZAG1)
Project Start
2016-05-01
Project End
2020-04-30
Budget Start
2016-05-01
Budget End
2017-04-30
Support Year
27
Fiscal Year
2016
Total Cost
Indirect Cost
Name
New York University
Department
Type
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Drummond, Eleanor; Nayak, Shruti; Pires, Geoffrey et al. (2018) Isolation of Amyloid Plaques and Neurofibrillary Tangles from Archived Alzheimer's Disease Tissue Using Laser-Capture Microdissection for Downstream Proteomics. Methods Mol Biol 1723:319-334
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Chen, Jingyun; Li, Yi; Pirraglia, Elizabeth et al. (2018) Quantitative evaluation of tau PET tracers 18F-THK5351 and 18F-AV-1451 in Alzheimer's disease with standardized uptake value peak-alignment (SUVP) normalization. Eur J Nucl Med Mol Imaging 45:1596-1604
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
de Leon, Mony J; Li, Yi; Rusinek, Henry (2018) Reply: Cerebrospinal Fluid, Hyposmia, and Dementia in Alzheimer Disease: Insights from Dynamic PET and a Hypothesis. J Nucl Med 59:718-719
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25
de Leon, Mony J; Pirraglia, Elizabeth; Osorio, Ricardo S et al. (2018) The nonlinear relationship between cerebrospinal fluid A?42 and tau in preclinical Alzheimer's disease. PLoS One 13:e0191240
Lakshmanan, Karthik; Brown, Ryan; Madelin, Guillaume et al. (2018) An eight-channel sodium/proton coil for brain MRI at 3 T. NMR Biomed 31:
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169

Showing the most recent 10 out of 604 publications